Close Menu

NEW YORK (GenomeWeb) – Bruker said today that its FluoroCycler XT PCR system and FluoroType MTBDR 2.0 Liquid Array assay for detecting tuberculosis and antibiotic resistance have received the CE-IVD mark.

According to Bruker, the PCR-based MTBDR test identifies pathogens directly from patient samples in three hours without the need for culturing. It can also detect more than 60 mutations in TB genes, which the company said can provide information on up to 522 patterns of antibiotic resistance, helping to guide therapy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.